Last reviewed · How we verify
NCT03585049
Microscopic Images for the Development of a Rapid Vaginitis Diagnostic Device
trial testing Vaginal swabs in Vaginitis in 500 participants. Completed in 1 December 2022.
1 December 2022
Quick facts
| Lead sponsor | Meir Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 October 2018 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Vaginal swabs
Conditions studied
- Vaginitis — all drugs for Vaginitis →
Sponsor
Meir Medical Center
Who can join
18 and older, female only, with Vaginitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study goal is to create an archive of microscopy images of various vulvovaginal inflammation conditions
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Diagnostic performance of an automated microscopy and pH test for diagnosis of vaginitis.
Lev-Sagie A, Strauss D, Ben Chetrit A. · · 2023 · cited 5× · PMID 37055473 · DOI 10.1038/s41746-023-00815-w
Verify or expand the search:
- PubMed search for NCT03585049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vaginal swabs
Trials testing the same drug.
- NCT04301401 — Assessment of Changes in Vaginal Microbiota Profiles Before and After Vaginal Urogynecologic Surgery · NA · completed
Other recruiting trials for Vaginitis
Currently open trials in the same condition.
- NCT06771063 — A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients · Phase 2 · recruiting
- NCT06070454 — Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant L · NA · recruiting
- NCT04574089 — Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository · Phase 3 · recruiting
Other Meir Medical Center trials
Trials by the same sponsor.
- NCT07256886 — Validation of the iCVS Model in Patients Admitted to the Intensive Care Unit · not yet recruiting
- NCT07315477 — Characteristics of Patients Intubated for Airway Protection in the Intensive Care Unit and Timing of Tracheostomy · not yet recruiting
- NCT07183410 — Impact of Blood Cultures Drawn From Arterial Lines on the Incidence of Contamination, Detection of Bacteremia, and Blood · not yet recruiting
- NCT07256860 — Influence of Chest X-ray vs. Chest CT Scan on the Management of ICU Patients With Respiratory Failure · not yet recruiting
- NCT05784350 — Preoperative Point of Care Ultrasound Guided Fluid Optimization and Intravenous Ondansetron to Prevent General Anesthesi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03585049 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meir Medical Center
- Last refreshed: 15 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03585049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing